Merck Animal Health shared earlier this week that the FDA approved its atinvicitinib tablets (NUMELVI; Merck Animal Health), a once daily, first line treatment for canine patients 6 months and older ...
HEART MONTH FOCUS: New Braunfels hospitals laud innovations in cardiovascular technology, procedures
Whether it be marking procedure milestones or implementing new technologies, New Braunfels’ local hospitals continue to make ...
Let's unpack the facts and do away with the stigma.
(HealthDay News) — Ultrasounds performed too early during hospitalization for first febrile urinary tract infection (fUTI) are more likely to produce false positives in young children, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results